Average Co-Inventor Count = 6.09
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (17 from 666 patents)
2. Incyte Holdings Corporation (4 from 147 patents)
3. Hercules Corporation (2 from 1,197 patents)
4. Boehringer Ingelheim Pharmaceuticals, Inc. (1 from 276 patents)
5. Incyte Incorporation (1 from 4 patents)
6. Inctye Holdings Corporation (1 from 1 patent)
21 patents:
1. 12459943 - Crystalline solid forms of a BET inhibitor
2. 12427154 - Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
3. 12043614 - Salts of a Pim kinase inhibitor
4. 12030882 - Crystalline solid forms of a bet inhibitor
5. 12024522 - Salts and processes of preparing a PI3K inhibitor
6. 11505540 - Salts of a Pim kinase inhibitor
7. 11452726 - Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
8. 11377446 - Crystalline solid forms of a BET inhibitor
9. 11091480 - Crystalline solid forms of a BET inhibitor
10. 11084822 - Salts and processes of preparing a PI3K inhibitor
11. 10799509 - Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
12. 10626114 - Crystalline solid forms of a BET inhibitor
13. 10336759 - Salts and processes of preparing a PI3K inhibitor
14. 10245265 - Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-B][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
15. 10189832 - Crystalline solid forms of a BET inhibitor